P

PILERI S

Last name: PILERI S

2004 (v1)

Publication

Metadata-only

Specific recognition of the viral protein UL18 by CD85j/LIR-1/ILT2 on CD8+ T cells mediates the non MHC-restricted lysis of hCMV-infected cells.

SAVERINO, DANIELE GHIOTTO, FABIO GIUSEPPE BRUNO, SILVIA

Immune evasion mechanisms of human CMV are known; however, the immune control of infection remains poorly elucidated. We show that interaction between the viral protein UL18 on infected cells and the invariant receptor CD85j/LIR-1/ILT2 expressed on CTL is relevant for the control of infection. Resting and activated CD8 T cells lysed UL18...

Uploaded on: April 14, 2023
2008 (v1)

Publication

Metadata-only

Fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in previously untreated patients with follicular non-Hodgkin lymphoma trial: a phase II non-randomised trial (FLUMIZ).

ZINZANI PL TANI M PULSONI A

Background Follicular lymphoma is the most common form of lymphoma in Europe and the USA. In this prospective, single-arm, open-labelled, multicentre non-randomised phase II trial (FLUMIZ [FLUdarabine, MItoxantrone, Zevalin] teal) we aimed to assess the efficacy and safety of fludarabine and mitoxantrone plus radioimmunotherapy in untreated...

Uploaded on: March 25, 2023